Compare, Analyse GSK Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs MYLAN (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   MYLAN
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
MYLAN
Dec-18
GSK PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,5953,493-   
Low Rs1,2531,923-   
Sales per share (Unadj.) Rs184.71,607.4-  
Earnings per share (Unadj.) Rs26.343.6-  
Cash flow per share (Unadj.) Rs29.2344.6-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.31,739.0-  
Shares outstanding (eoy) m169.40514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.11.7 779.2%   
Avg P/E ratio x92.262.0 148.6%  
P/CF ratio (eoy) x83.17.9 1,057.8%  
Price / Book Value ratio x19.21.6 1,232.2%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6261,393,313 29.5%   
No. of employees `0005.035.0 14.2%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.723,629.5 26.7%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0641.6 140.0%   
INCOME DATA
Net Sales Rs m31,281827,032 3.8%  
Other income Rs m1,0230-   
Total revenues Rs m32,304827,032 3.9%   
Gross profit Rs m6,009214,005 2.8%  
Depreciation Rs m486154,853 0.3%   
Interest Rs m639,777 0.0%   
Profit before tax Rs m6,54019,375 33.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373-3,082 -77.0%   
Profit after tax Rs m4,45422,457 19.8%  
Gross profit margin %19.225.9 74.2%  
Effective tax rate %36.3-15.9 -228.1%   
Net profit margin %14.22.7 524.4%  
BALANCE SHEET DATA
Current assets Rs m20,061461,814 4.3%   
Current liabilities Rs m14,543336,713 4.3%   
Net working cap to sales %17.615.1 116.6%  
Current ratio x1.41.4 100.6%  
Inventory Days Days5784 67.9%  
Debtors Days Days1493 15.1%  
Net fixed assets Rs m14,343160,431 8.9%   
Share capital Rs m1,694440 384.7%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,398894,697 2.4%   
Long term debt Rs m2965,666 0.0%   
Total assets Rs m39,1132,399,926 1.6%  
Interest coverage x1,091.01.5 73,365.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 232.1%   
Return on assets %11.42.6 439.7%  
Return on equity %20.82.5 829.3%  
Return on capital %31.93.2 1,004.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994171,857 2.3%  
From Investments Rs m-1,433-88,831 1.6%  
From Financial Activity Rs m-3,584-80,061 4.5%  
Net Cashflow Rs m-1,0231,424 -71.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.39 Rs / USD

Compare GSK PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: CIPLA  AJANTA PHARMA  SUVEN LIFESCIENCES  ALEMBIC PHARMA  FDC.  



Today's Market

Sensex Ends 163 Points Higher; Metal and Realty Stocks Witness Buying(Closing)

It was indeed a volatile trading day for share markets in India today. After staging a gap-up opening, Indian share markets reversed gains.

Related Views On News

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


Oct 21, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 5-YR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

Why ITC and not HUL is my Idea of a Good Investment Right Now

Contrarian Trading in PSU Banks

Why I Asked My Subscribers to Sell Stocks and Move into Cash?

How to Save Money by Exiting Stocks Before They Fall

More Featured Videos

MARKET STATS